Skip to content

NXXT NXXT Deferred offering costs

Deferred offering costs at other companies

Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$164.72K
Hitachi logo
HitachiHIT
$170.98K
NextNRG, Inc. Common Stock logo
NextNRG, Inc. Common StockNXXT
$18.09K-98.8%
IRA
Iris Acquisition IRAB
$0
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$3.29M-24.2%
DeFi Development Corp. Common Stock logo
DeFi Development Corp. Common StockDFDV
$3.36M+2,861%

Other financials

Income statement

See full
Revenue$21.1M+29.4%
Gross profit$1.7M+230%
Operating income-$10.1M-75.4%
Net income-$10.7M-22.1%
EPS (diluted)-$0.07+95.6%

Balance sheet

See full
Cash & equivalents$208.0K-90.2%
Total debt$3.4M+4,849%
Total equity-$19.6M-252%
Total assets$12.3M-52.9%

Cash flow

See full
Operating cash flow-$2.1M+62.8%
CapEx$5.7M+26,892%
Free cash flow-$7.2M-490%

Valuation

See full
Market cap$55.34M-82.7%
Enterprise value$58.5M-81.6%
P/S0.6×-5.8×

Profitability

See full
Gross margin9.4%+4.4pp
Operating margin-86%-1,407pp
Net margin-101.1%+60.1pp
FCF margin-43%

Returns & leverage

See full
Return on equity-1,208.8%-1,564pp
Debt / equity0.3×-56.1×
Current ratio0.2×0.0×

Where this comes from

Reported directly by NXXT in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: NXXT’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NXXT's deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NXXT's deferred offering costs?
NXXT (NXXT) reported deferred offering costs of $18.09K in Q1 2026.
How has NXXT's deferred offering costs changed year-over-year?
NXXT's deferred offering costs decreased by 98.8% year-over-year, from $1.54M to $18.09K.
What is the long-term trend for NXXT's deferred offering costs?
Over 3 years (2020 to 2025), NXXT's deferred offering costs has grown at a -51.0% compound annual growth rate (CAGR), from $153.6K to $18.09K.
What does deferred offering costs mean?
These are costs incurred in connection with the issuance of equity or debt securities that are capitalized and amortized over the life of the instrument. They represent upfront expenditures required to raise capital, such as legal, accounting, and registration fees. Tracking these costs helps in understanding the efficiency of the company's capital-raising activities.